VIII. symposium NATA

Európa 20.4.2007 – 21.4.2007 ·symposium
Téma transfúzna medicína a príbuzné témy
Miesto Novotel Budapest Congress & World Trade Centre , Budapest , Maďarsko
Web www.nataonline.com/AGEUpcNATCon2.php3?NumUp=165&TypeUp=NATA
Materiály www.c-travel.hu/eng/datasheet/novotel_budapest_congress%3Cbr%3Ebudapest_congress_world_trade_center
Dokument nata1.pdf
8th Annual NATA Symposium

Friday, April 20, 2007

MORNING

8:45-9:00 Welcome Address
Alice Maniatis, Athens, Greece

AGE OF BLOOD: DOES IT MATTER?

9:00-9:20 Does it Matter for the Brain?
Richard B. Weiskopf, San Francisco, CA, USA

9:20-9:40 Does it Matter in Cardiac Surgery?
TBD

9:40-10:00 Does it Matter in Critical Care?
Stuart McLellan, Edinburgh, Scotland, UK

10:00-10:30 Questions and Answers

10:30-11:00 Break


VOLUME REPLACEMENT – PATRIA AUDITORIUM

11:00-11:20 Colloids: A Systematic Review
Sylvain Bélisle, Montreal, QC, Canada

11:20-11:40 Balanced Electrolyte Solutions
Rolf Zander, Mainz, Germany

11:40-12:00 Fluid Management in Fast-Track Surgery
Henrik Kehlet, Copenhagen, Denmark

12:00-12:30 Questions and Answers


ANEMIA AND THE BRAIN – BARTOK HALL

11:00-11:20 Anemia and the Brain
Philippe Van der Linden, Brussels, Belgium

11:20-11:40 Transfusion and the Brain
Santiago R. Leal-Noval, Seville, Spain

11:40-12:00 Erythropoietin and the Brain
Hannelore Ehrenreich, Göttingen, Germany

12:00-12:30 Questions and Answers

12:30-14:30 Lunch


Friday, April 20, 2007

AFTERNOON

COMPLICATIONS OF TRANSFUSION – PATRIA AUDITORIUM

14:30-14:50 Emerging Transfusion-Transmitted Infections
John A. J. Barbara, London, UK

14:50-15:10 Immunological Side Effects of Blood Transfusion
Volker Kretschmer, Marburg, Germany

15:10-15:30 Risk Management in Transfusion Medicine
Loukia Loukopoulos, Athens, Greece

15:30-16:00 Questions and Answers


HEMOSTASIS – BARTOK HALL

14:30-14:50 Management of Coagulation Disorders in Major Bleeding
George G. Despotis, St. Louis, MO, USA

14:50-15:10 Recombinant Activated Factor VII Is Safe and Effective in the Management of Critical Bleeding. Pro
Richard B. Weiskopf, San Francisco, CA, USA

15:10-15:30 Recombinant Activated Factor VII Is Safe and Effective in the Management of Critical Bleeding. Con
Jean-François Hardy, Montreal, QC, Canada

15:30-16:00 Questions and Answers

16:00-16:30 Break


TRANSFUSION IN PEDIATRICS – PATRIA AUDITORIUM

16:30-16:50 Transfusion in the Pediatric Intensive Care Unit
Jacques Lacroix, Montreal, QC, Canada

16:50-17:10 Is It Safe to Limit Allogeneic Red Blood Cell Transfusions During Infancy?
Ronald G. Strauss, Iowa City, IO, USA

17:10-17:30 Coagulation Monitoring in Pediatric Surgery
Hans Gombotz, Linz, Austria

17:30-18:00 Questions and Answers


ORAL COMMUNICATIONS – BARTOK HALL

10 min presentations followed by 5 min discussions
6 presentations

18:00 End of Session


18:15-19:00 NATA General Assembly


Saturday, April 21, 2007

MORNING

PRO AND CON DISCUSSION: BLOOD SALVAGE IN OBSTETRIC HEMORRHAGE

9:00-9:20 Blood Salvage in Obstetric Hemorrhage. Con
Hans Gombotz, Linz, Austria

9:20-9:40 Blood Salvage in Obstetric Hemorrhage. Pro
Dafydd Thomas, Swansea, UK

9:40-10:00 Questions and Answers


STATE-OF-THE-ART LECTURE

10:00-10:30 Acute Normovolemic Hemodilution
Konrad Messmer, Munich, Germany

10:30-11:00 Break


HEMOSTASIS – PATRIA AUDITORIUM

11:00-11:20 Perioperative Management of New Antithrombotic Agents
Charles-Marc Samama, Paris, France

11:20-11:40 Management of Patients With Recent Stenting
Helfried Metzler, Graz, Austria

11:40-12:00 Point-of-Care Monitoring for the Diagnosis and Optimal Management of Bleeding
George G. Despotis, St. Louis, MO, USA

12:00-12:30 Questions and Answers


MANAGEMENT OF BLOOD RESOURCES – BARTOK HALL

11:00-11:20 Advantages of Centralization of National Blood Services
Marcela Contreras, London, UK

11:20-11:40 Advantages of Decentralized Blood Services
Hans Erik Heier, Oslo, Norway

11:40-12:00 Legal Issues in Autologous Blood Use
Manuel Muñoz, Málaga, Spain

12:00-12:30 Questions and Answers

12:30-14:30 Lunch


Saturday, April 21, 2007

AFTERNOON

TRANSFUSION IN CRITICAL CARE – PATRIA AUDITORIUM

14:30-14:50 What Is the Threshold for RBC Transfusion?
Stuart McLellan, Edinburgh, Scotland, UK

14:50-15:10 Prophylactic Administration of FFP and Platelets
Ognjen Gajic, Rochester, MN, USA

15:10-15:30 Erythropoietin Therapy in Critically Ill Patients
Dimitris Georgopoulos, Heraklion, Crete, Greece

15:30-16:00 Questions and Answers


VOLUME REPLACEMENT – BARTOK HALL

14:30-14:50 Volume Optimization in Surgical Patients
Philippe Van der Linden, Brussels, Belgium

14:50-15:10 Crystalloid Restriction in Surgical Patients
Michael F. M. James, Western Cape, South Africa

15:10-15:30 Hydroxyethyl Starch and Inflammation
Heinz-Jürgen Dieterich, Tübingen, Germany

15:30-16:00 Questions and Answers

16:00-16:30 Break


ANEMIA MANAGEMENT

16:30-16:50 Guidelines on Intravenous Iron Supplementation in Surgery and Obstetrics/Gynecology
Photis Beris, Geneva, Switzerland

16:50-17:10 Report of NATA Expert Meeting on Blood Conservation in Orthopedic Surgery
Peter Earnshaw, London, Uk

17:10-17:30 Managing Severe Anemia in Africa: Opportunities and Challenges
Imelda Bates, Liverpool, UK

17:30-18:00 Questions and Answers

18:00 Concluding Comments
Alice Maniatis, Athens, Greece